Kidney Cancer Guide: Treatment Anti-VEGF

Treatments

Treatment Category Profile

Treatment Name: Anti-VEGF Known as:

Also Known As: Anti-VEGF

Treatment Type: Anti-Angiogenesis Status: FDA Approved (phase II)

VEGF, vascular endothelial growth factor, is a chemical signal which cancer cells send to initiate vascular growth. Anti-VEGF is a drug intended to inhibit this signaling process, and starve the tumor of nutrients without attacking it directly. It is a member of a category of therapies called anti-angiogenesis.

Articles related to this Treatment

1 Association of tumour burden debulking nephrectomy and progression-free survival. Docguide.com Mar 23, 2010

2 Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy Journal of Clinical Oncology Jan 10, 2009

3 Scientists hope protein is the tap to turn off tumour growth SMH Jul 16, 2002

4 2 new cancer fighters hold promise in trials Boston Globe May 22, 2000

Treatment Name:	Anti-VEGF	Known as: Also Known As:	Anti-VEGF
Treatment Type:	Anti-Angiogenesis	Status:	FDA Approved (phase II)
VEGF, vascular endothelial growth factor, is a chemical signal which cancer cells send to initiate vascular growth. Anti-VEGF is a drug intended to inhibit this signaling process, and starve the tumor of nutrients without attacking it directly. It is a member of a category of therapies called anti-angiogenesis.